Acute myeloid leukemia surgery: Difference between revisions
Category |
Shyam Patel (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Acute myeloid leukemia}} | {{Acute myeloid leukemia}} | ||
{{CMG}}; {{AE}} {{RT}} {{CLG}} | {{CMG}}; {{AE}} {{RT}} {{CLG}} {{shyam}} | ||
==Overview== | ==Overview== | ||
| Line 7: | Line 7: | ||
==Surgery== | ==Surgery== | ||
[[Surgery]] plays a small role in the treatment of acute myelogenous leukemia. Surgery is used to place a venous access device as a port through which [[chemotherapy]] can be delivered. The port is susceptible to [[infection]] and therefore must be cared for appropriately. | [[Surgery]] plays a small role in the treatment of acute myelogenous leukemia. Surgery is used to place a venous access device as a port through which [[chemotherapy]] can be delivered. The port is susceptible to [[infection]] and therefore must be cared for appropriately. There is a risk for infection with port placement.<ref name="pmid24570595">{{cite journal| author=Bustos C, Aguinaga A, Carmona-Torre F, Del Pozo JL| title=Long-term catheterization: current approaches in the diagnosis and treatment of port-related infections. | journal=Infect Drug Resist | year= 2014 | volume= 7 | issue= | pages= 25-35 | pmid=24570595 | doi=10.2147/IDR.S37773 | pmc=3933716 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24570595 }} </ref> | ||
==References== | ==References== | ||
Revision as of 22:51, 31 October 2018
|
Acute myeloid leukemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Acute myeloid leukemia surgery On the Web |
|
American Roentgen Ray Society Images of Acute myeloid leukemia surgery |
|
Risk calculators and risk factors for Acute myeloid leukemia surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2] Carlos A Lopez, M.D. [3] Shyam Patel [4]
Overview
Surgery is not the first-line treatment option for patients with acute myeloid leukemia.
Surgery
Surgery plays a small role in the treatment of acute myelogenous leukemia. Surgery is used to place a venous access device as a port through which chemotherapy can be delivered. The port is susceptible to infection and therefore must be cared for appropriately. There is a risk for infection with port placement.[1]
References
- ↑ Bustos C, Aguinaga A, Carmona-Torre F, Del Pozo JL (2014). "Long-term catheterization: current approaches in the diagnosis and treatment of port-related infections". Infect Drug Resist. 7: 25–35. doi:10.2147/IDR.S37773. PMC 3933716. PMID 24570595.